Research, Innovation & Emerging Technology, Clinical Outcomes & Patient Safety
The Janssen Pharmaceutical Companies of Johnson & Johnson is now J&J Innovative Medicine. We’ve been part of Johnson & Johnson and now our identity better conveys that. Our new brand truly reflects the best of who we are and what we do to lead where medicine is going.
Patients inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science and compassion, we confidently address some of the most complex diseases of our time and unlock the potential medicines of tomorrow.
Our diverse portfolio spans multiple therapeutic areas — Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.
We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way.
Share it with your network and help spread clinical knowledge.
